DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 4Strides Pharma Science
03 4Granules India Limited
04 4ATNAHS PHARMA UK LIMITED
05 7Actavis Inc
06 3Adamed Pharma
07 1Aeon Formulations Private Limited
08 4Amneal Pharmaceuticals
09 1Antibiotice SA
10 2Apotex Inc
11 1Aralez Pharmaceuticals
12 1Ascent Innovative Medicines
13 5Aurobindo Pharma Limited
14 12Bayer AG
15 4Biofarma Pharmaceutical Industry and Commerce Inc
16 1Bionpharma
17 1Catalent Pharma Solutions
18 2Contract Pharmacal Corporation
19 1CorePharma, LLC
20 2Currax
21 2Glenmark Pharmaceuticals
22 1Grup Farma
23 2Hamilton
24 1Hetero Drugs
25 2Hikma Pharmaceuticals
26 1Holden Medical Laboratories Pvt. Ltd
27 2IVAX Pharmaceuticals Inc
28 1LNK
29 1Madras Pharmaceuticals
30 1Marksans Pharma
31 4Mars Therapeutics & Chemicals
32 1Meda OTC AB,
33 1Myungmoon Pharm. Co., LTD.
34 2NORVIUM BIOSCIENCE
35 2Noripharma
36 1Novelgenix
37 1PL Developments
38 1PLD ACQUISITIONS
39 2PRO DOC LIMITEE
40 1PURACAP PHARM
41 2PUREPAC PHARM
42 1Par Pharmaceutical
43 1Patheon
44 1Patheon Softgels BV
45 3Perrigo Company plc
46 4Pharmascience Inc.
47 2Pliva Hrvatska
48 2ROXANE
49 1Rising Pharmaceuticals Inc
50 4Sandoz B2B
51 2ScieGen Pharmaceuticals
52 1Seoul Pharma Co Ltd
53 4Sun Pharmaceutical Industries Limited
54 2T.M.Thakore Pharmaceutical Laboratories
55 3TWi Pharmaceuticals
56 8Teva Pharmaceutical Industries
57 2Umedica Laboratories
58 1Whanin Pharmaceutical
59 2World Medicine
60 3XYZ Pharma
61 2Yichang Humanwell Pharmaceutical
62 2Zim Laboratories
63 5Blank
01 1BILAYERED TABLET
02 2CAP
03 3CAPSULE
04 5CAPSULE;ORAL
05 1Capsule
06 3DC Granules
07 2DC Granules and Tablets
08 2ENTERIC COATED TABLETS
09 4FC Tablet
10 2FILM COATED TABLET
11 1FILMDRAGERAD TABLETT
12 2Film Coated Tablet
13 2Film-Coated Tablet
14 1Immediate Release Tablet
15 2Oral Solid Dosage Form
16 1Pellets
17 1SOFT CAPSULE
18 1Soft Gel
19 1Soft Gel Capsule
20 2Softgelatin Capsule
21 2TAB
22 20TABLET
23 10TABLET, EXTENDED RELEASE;ORAL
24 2TABLET; ORAL
25 68TABLET;ORAL
26 10Tablet
27 1modi?ed-release tablets
01 38DISCN
02 11Generic
03 2Lead Market Dossiers- Filed
04 33OTC
05 4Originator
06 9Prescription
07 1ROW, US
08 21RX
09 1TP, ODMF
10 32Blank
01 1 Compresso NAP 73.3
02 110 Antalgin 550Mg Film-Coated Tablets
03 140 Antalgin 550Mg Film-Coated Tablets
04 1ALEVE
05 1ALEVE BACK AND BODY PAIN
06 1ALEVE CAPLETS
07 1ALEVE LIQUID GELS
08 1ALEVE NIGHTTIME
09 1ALEVE PM
10 1ALEVE-D SINUS & COLD
11 2ANAPROX
12 2ANAPROX DS
13 1APO-NAPRO-NA
14 1APO-NAPRO-NA DS
15 4Aleve
16 1Anax
17 1Eox
18 1MAXIDOL LIQUID GELS
19 1NAPOLON
20 3NAPRELAN
21 2NAPROXEN
22 2NAPROXEN MENSTRUAL PAIN RELIEF
23 62NAPROXEN SODIUM
24 5NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
25 3NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
26 1NAPROXEN-NA
27 1NAPROXEN-NA DF
28 1NAPROXEN/ESOMEPRAZOLE
29 1Napren S Fort
30 1Naproxen
31 1Naproxen Banner
32 1Naproxen Sodium Cinfa 550Mg 10 Tablets Efg
33 1Naproxen Sodium Cinfa 550Mg 40 Tablets Efg
34 1P.P. NAPROXEN NA 275MG TABLET
35 1P.P. NAPROXEN NA 550MG
36 3SUMATRIPTAN AND NAPROXEN SODIUM
37 2SUMATRIPTAN; NAPROXEN SODIUM
38 1SUVEXX
39 4Synax
40 1TEVA-NAPROXEN SODIUM
41 1TEVA-NAPROXEN SODIUM DS
42 2TREXIMET
43 2UPROGESIC
44 25Blank
01 18Canada
02 1China
03 22India
04 2Malaysia
05 3Poland
06 1Romania
07 4South Africa
08 3South Korea
09 4Spain
10 2Sweden
11 7Turkey
12 85USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : OTC
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 220MG
Packaging :
Approval Date : 1998-07-28
Application Number : 75168
Regulatory Info : OTC
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2022-08-17
Application Number : 215472
Regulatory Info : DISCN
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : OTC
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 220MG
Packaging :
Approval Date : 2011-09-20
Application Number : 91353
Regulatory Info : OTC
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : OTC
Registration Country : USA
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 220MG;120MG
Packaging :
Approval Date : 2006-09-27
Application Number : 77381
Regulatory Info : OTC
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Esomeprazole Magnesium; Naproxen Sodium
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG; 375MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Esomeprazole Magnesium; Naproxen Sodium
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Soft Gel Capsule
Dosage Strength : 220MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : OTC
Registration Country : USA
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Brand Name : NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG;220MG
Packaging :
Approval Date : 2020-09-24
Application Number : 213663
Regulatory Info : OTC
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : TP, ODMF
Registration Country : India
Brand Name : Compresso NAP 73.3
Dosage Form : Pellets
Dosage Strength : 73.3%
Packaging :
Approval Date :
Application Number :
Regulatory Info : TP, ODMF
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW, US
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 220MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW, US
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Packaging :
Approval Date : 1993-12-21
Application Number : 74195
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 500MG BASE
Packaging :
Approval Date : 1993-12-21
Application Number : 74195
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAPROX
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 18164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANAPROX DS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 500MG BASE
Packaging :
Approval Date : 1987-09-30
Application Number : 18164
Regulatory Info : RX
Registration Country : USA
Regulatory Info : OTC
Registration Country : USA
Brand Name : ALEVE
Dosage Form : TABLET;ORAL
Dosage Strength : 220MG
Packaging :
Approval Date : 1994-01-11
Application Number : 20204
Regulatory Info : OTC
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : ALEVE-D SINUS & COLD
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 220MG;120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1999-11-29
Application Number : 21076
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : OTC
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2006-02-17
Application Number : 21920
Regulatory Info : OTC
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Brand Name : TREXIMET
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;EQ 85MG BASE
Packaging :
Approval Date : 2008-04-15
Application Number : 21926
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Brand Name : TREXIMET
Dosage Form : TABLET;ORAL
Dosage Strength : 60MG;EQ 10MG BASE
Packaging :
Approval Date : 2015-05-14
Application Number : 21926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Packaging :
Approval Date : 1993-08-31
Application Number : 74106
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 500MG BASE
Packaging :
Approval Date : 1993-08-31
Application Number : 74106
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Packaging :
Approval Date : 1993-12-21
Application Number : 74162
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 500MG BASE
Packaging :
Approval Date : 1993-12-21
Application Number : 74162
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Packaging :
Approval Date : 1993-12-21
Application Number : 74142
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 500MG BASE
Packaging :
Approval Date : 1993-12-21
Application Number : 74142
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NAPRELAN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 375MG BASE
Packaging :
Approval Date : 1996-01-05
Application Number : 20353
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NAPRELAN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 500MG BASE
Packaging :
Approval Date : 1996-01-05
Application Number : 20353
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NAPRELAN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 750MG BASE
Packaging :
Approval Date : 1996-01-05
Application Number : 20353
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?
